Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing-Reference-Cited by-同舟云学术

Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing

Published:2019-10-28 Issue:10 Volume:14 Page:e0224097
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Balagopal Vidya^ORCID,Hantel Andrew,Kadri Sabah,Steinhardt George,Zhen Chao Jie,Kang Wenjun,Wanjari Pankhuri,Ritterhouse Lauren L.,Stock Wendy,Segal Jeremy P.

Funder

AbbVie

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes;BL Scott;J Clin Oncol,2017

2. Molecular Minimal Residual Disease Testing in Acute Myeloid Leukemia: A Review for the Practicing Clinician;A Hantel;Clinical Lymphoma, Myeloma and Leukemia,2018

3. Minimal Residual Disease in Acute Myeloid Leukemia: Still a Work in Progress?;F Mosna;J Clin Med,2017

4. Should minimal residual disease guide therapy in AML?;E Paietta;Best Pract Res Clin Haematol,2015

5. Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party;GJ Schuurhuis;Blood,2018

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-wide direct quantification of in vivo mutagenesis using high-accuracy paired-end and complementary consensus sequencing;Nucleic Acids Research;2023-10-23

2. Moving toward a conceptualization of measurable residual disease in myelodysplastic syndromes;Blood Advances;2023-08-10

3. Novel precision medicine approaches and treatment strategies in hematological malignancies;Journal of Internal Medicine;2023-08-07

4. Optimizing Donor Chimerism Threshold for Next-Generation Sequencing Monitoring of Measurable Residual Disease Post-Allogeneic Stem Cell Transplantation for Myeloid Neoplasms;Transplantation and Cellular Therapy;2023-07

5. Molecular MRD Assessment in Acute Myeloid Leukemias;Indian Journal of Medical and Paediatric Oncology;2023-04-17